| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||
| Chlorophyllin is a semi-synthetic derivative of chlorophyll, the green pigment found in plants that is essential for photosynthesis. -Antioxidant Activity -Detoxification -Inhibition of Tumor Growth(unknown pathway?) -Modulation of Gene Expression -Anti-inflammatory Effects Dose: 100-300mg/d split 1-3x/d Chlorophyllin — Chlorophyllin is a semi-synthetic, water-soluble copper-containing derivative mixture of plant chlorophyll, most commonly used as sodium copper chlorophyllin. It is best classified as a semi-synthetic small-molecule phytochemical derivative that also functions as a food color additive, OTC deodorant drug ingredient, and chemopreventive “interceptor” candidate rather than a validated systemic anticancer drug. Standard abbreviations include CHL and, for the common oral form, SCC (sodium copper chlorophyllin). It originates from natural chlorophyll after saponification and copper substitution to improve water solubility and stability. The strongest translational evidence is for oral reduction of carcinogen bioavailability and DNA-adduct burden in exposure settings; direct tumoricidal signaling effects are mostly preclinical, and photodynamic use is a distinct external-trigger application. Chlorophyll (Chl), the parent compound of CHL, is readily available by consumption of green vegetables.Primary mechanisms (ranked):
Bioavailability / PK relevance: Oral chlorophyllin is relatively digestive-stable and can interact with intestinal cells, but available PK data suggest limited systemic serum exposure, with significant luminal retention and efflux likely contributing to its dominant gastrointestinal interception profile. Some animal work suggests tissue distribution can occur, but standard oral use does not support assuming high free systemic tumor exposure. In-vitro vs systemic exposure relevance: Common direct anticancer in-vitro studies likely use concentrations above what is reliably achievable in systemic circulation with ordinary oral dosing. Its most credible non-PDT human effect is not high plasma tumor exposure but reduced carcinogen uptake and biomarker damage. In PDT contexts, efficacy is not ordinary concentration-driven alone and requires an external light trigger. Clinical evidence status: Human evidence is strongest for chemopreventive biomarker modulation, including a randomized placebo-controlled trial showing reduced aflatoxin biomarker burden in a high-risk population. Evidence for direct cancer treatment remains preclinical or adjunctive/emerging, while newer studies in radiation-related injury are not yet proof of anticancer efficacy. Mechanistic table
TSF legend: P: 0–30 min |
| Source: |
| Type: |
| Also known as HSPA5 Enhanced expression of Hsp70 is associated with tumorigenesis for breast cancer, endometrial cancer, gastric cancer, and acute leukemia; with poor prognoses. -These adenosine triphosphatases unfold misfolded or denatured proteins and can keep these proteins in an unfolded, folding-competent state. They also protect nascently translating proteins, promote the cellular or organellar transport of proteins, reduce proteotoxic protein aggregates and serve general housekeeping roles in maintaining protein homeostasis. -HSP70 family of proteins can be thought of as a potent buffering system for cellular stress, either from extrinsic (physiological, viral and environmental) or intrinsic (replicative or oncogenic) stimuli. As such, this family serves a critical survival function in the cell. Not surprisingly, cancer cells rely heavily on this buffering system for survival. The overwhelming majority of human tumors overexpress HSP70 family members, and expression of these proteins is typically a marker for poor prognosis. -HSP70 helps cancer cells survive under stressful conditions, such as hypoxia or nutrient deprivation, by preventing protein misfolding and aggregation. This allows cancer cells to maintain their proliferative capacity. -Tumor Progression: Elevated levels of HSP70 have been associated with tumor progression and metastasis. |
| 6073- | CHL, | GEM, | Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis |
| - | in-vitro, | PC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:218 Target#:148 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid